These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 22606350)
1. Vitronectin increases vascular permeability by promoting VE-cadherin internalization at cell junctions. Li R; Ren M; Chen N; Luo M; Zhang Z; Wu J PLoS One; 2012; 7(5):e37195. PubMed ID: 22606350 [TBL] [Abstract][Full Text] [Related]
2. Vitronectin regulation of vascular endothelial growth factor-mediated angiogenesis. Li R; Luo M; Ren M; Chen N; Xia J; Deng X; Zeng M; Yan K; Luo T; Wu J J Vasc Res; 2014; 51(2):110-7. PubMed ID: 24603119 [TBL] [Abstract][Full Text] [Related]
3. The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells. Alghisi GC; Ponsonnet L; Rüegg C PLoS One; 2009; 4(2):e4449. PubMed ID: 19212436 [TBL] [Abstract][Full Text] [Related]
4. Nitric Oxide Increases Arterial Endotheial Permeability through Mediating VE-Cadherin Expression during Arteriogenesis. Yang B; Cai B; Deng P; Wu X; Guan Y; Zhang B; Cai W; Schaper J; Schaper W PLoS One; 2015; 10(7):e0127931. PubMed ID: 26133549 [TBL] [Abstract][Full Text] [Related]
5. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway. Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831 [TBL] [Abstract][Full Text] [Related]
6. VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. Sun Z; Li X; Massena S; Kutschera S; Padhan N; Gualandi L; Sundvold-Gjerstad V; Gustafsson K; Choy WW; Zang G; Quach M; Jansson L; Phillipson M; Abid MR; Spurkland A; Claesson-Welsh L J Exp Med; 2012 Jul; 209(7):1363-77. PubMed ID: 22689825 [TBL] [Abstract][Full Text] [Related]
7. Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers. Adam AP; Sharenko AL; Pumiglia K; Vincent PA J Biol Chem; 2010 Mar; 285(10):7045-55. PubMed ID: 20048167 [TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation. Lee CS; Kim YG; Cho HJ; Park J; Jeong H; Lee SE; Lee SP; Kang HJ; Kim HS Sci Rep; 2016 Jul; 6():29393. PubMed ID: 27381080 [TBL] [Abstract][Full Text] [Related]
9. ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin. Schulz B; Pruessmeyer J; Maretzky T; Ludwig A; Blobel CP; Saftig P; Reiss K Circ Res; 2008 May; 102(10):1192-201. PubMed ID: 18420943 [TBL] [Abstract][Full Text] [Related]
10. Losartan protects against myocardial ischemia and reperfusion injury Li Y; Yao Y; Li J; Chen Q; Zhang L; Wang QK FASEB J; 2019 Jul; 33(7):8555-8564. PubMed ID: 30991833 [TBL] [Abstract][Full Text] [Related]
11. Dynamic Regulation of Vascular Permeability by Vascular Endothelial Cadherin-Mediated Endothelial Cell-Cell Junctions. Rho SS; Ando K; Fukuhara S J Nippon Med Sch; 2017; 84(4):148-159. PubMed ID: 28978894 [TBL] [Abstract][Full Text] [Related]
12. Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase. Xu M; Waters CL; Hu C; Wysolmerski RB; Vincent PA; Minnear FL Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1309-18. PubMed ID: 17670896 [TBL] [Abstract][Full Text] [Related]
13. Enhanced endothelial barrier function by monoclonal antibody activation of vascular endothelial cadherin. Park KS; Schecterson L; Gumbiner BM Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1403-H1410. PubMed ID: 33577432 [TBL] [Abstract][Full Text] [Related]
14. SHP2 protects endothelial cell barrier through suppressing VE-cadherin internalization regulated by MET-ARF1. Zhang J; Huang J; Qi T; Huang Y; Lu Y; Zhan T; Gong H; Zhu Z; Shi Y; Zhou J; Yu L; Zhang X; Cheng H; Ke Y FASEB J; 2019 Jan; 33(1):1124-1137. PubMed ID: 30102570 [TBL] [Abstract][Full Text] [Related]
15. eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases. Di Lorenzo A; Lin MI; Murata T; Landskroner-Eiger S; Schleicher M; Kothiya M; Iwakiri Y; Yu J; Huang PL; Sessa WC J Cell Sci; 2013 Dec; 126(Pt 24):5541-52. PubMed ID: 24046447 [TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation of vascular endothelial cadherin and the regulation of microvascular permeability. Nwariaku FE; Liu Z; Zhu X; Turnage RH; Sarosi GA; Terada LS Surgery; 2002 Aug; 132(2):180-5. PubMed ID: 12219009 [TBL] [Abstract][Full Text] [Related]
17. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions. Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220 [TBL] [Abstract][Full Text] [Related]
18. Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-β1/ERK/caspase-9 phosphorylation cascade. Lee SW; Won JY; Lee HY; Lee HJ; Youn SW; Lee JY; Cho CH; Cho HJ; Oh S; Chae IH; Kim HS Mol Med; 2011; 17(9-10):1095-106. PubMed ID: 21738954 [TBL] [Abstract][Full Text] [Related]